Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-17

Clinical Trial Update: Prevention of Vaso-occlusive Painful Crisis by Using Omega-3 Fatty Acid Supplements [Phase 3]

View source ↗

Summary

This is an update on a Phase 3 trial evaluating omega-3 fatty acid supplements to prevent vaso-occlusive painful crises in sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 Fatty Acid Supplements (Omega-3 fatty acids)

Snippet

Sponsor: Sultan Qaboos University | Conditions: Sickle Cell Disease | Phase 3 | Status: UNKNOWN